(Q28298974)

1

0 references

Martha Kanemitsu-Parks

2

0 references

Ibragim Gaidarov

3

0 references

Jill S Cameron

4

0 references

Peter Griffin

5

0 references

Hong Zheng

6

0 references

Nuvia C Guerra

7

0 references

Linda Cham

8

0 references

Dominique Maciejewski-Lenoir

9

0 references

Dominic P Behan

10

0 references

Doug Boatman

11

0 references

Ruoping Chen

12

0 references

Philip Skinner

13

0 references

Pricilla Ornelas

14

0 references

M Gerard Waters

15

0 references

Samuel D Wright

16

0 references

Graeme Semple

17

0 references

Daniel T Connolly

Journal of Biological Chemistry

18

0 references

language of work or name

English

0 references

publication date

22 June 2007

0 references

published in

0 references

volume

282

0 references

issue

25

0 references

page(s)

18028-36

0 references

cites work

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Inhibition of the mobilization of free fatty acids from adipose tissue. Physiological aspects on the mechanisms for the inhibition of mobilization of FFA from adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Molecular identification of high and low affinity receptors for nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Molecular identification of nicotinic acid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Nicotinic acid-induced flushing is mediated by activation of epidermal langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Langerhans cells release prostaglandin D2 in response to nicotinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Pyrazole derivatives as partial agonists for the nicotinic acid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

(D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Essential role for G protein-coupled receptor endocytosis in the activation of mitogen-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Agonist-receptor efficacy. II. Agonist trafficking of receptor signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Heterozygous alpha 2A-adrenergic receptor mice unveil unique therapeutic benefits of partial agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200

Selectivity of action of 8-alkylamino analogues of N6-cyclopentyladenosine in vivo: haemodynamic versus anti-lipolytic responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M701866200